Mayne Pharma, Metrics Plan $65 M Mfg Expansion
Mayne Pharma, the parent company of the contract development and manufacturing organization, Metrics Contract Services, will invest $65 million to expand facilities and equipment at the company’s site in Greenville, North Carolina. The company's plans include the greenfield construction of a new, 126,000-square-foot, large-scale oral-dose manufacturing facility, along with the re-purposing of existing space to expand contract services. The company currently employs 350 people in North Carolina and anticipates hiring up to 110 more scientists, quality assurance specialists, manufacturing operators and technicians to support the expanded operations footprint.
Mayne Pharma will construct the new facility on a campus that houses Mayne Pharma's products business, along with Metrics Contract Services. Metrics was acquired in 2012 by Mayne Pharma, a publicly held specialty pharmaceutical company headquartered in Adelaide, Australia. Mayne Pharma's operations in the United States consist of: Metrics Contract Services, which provides contract pharmaceutical development services to third parties globally; US Generic Products, which develops, manufactures, markets and distributes generic drug products; and US Specialty Brands, which is responsible for the marketing and distribution of branded pharmaceuticals within the United States.
The new facility will allow Mayne Pharma to expand development, manufacturing, and packaging operations for generic and specialty drug products and expand services to Metrics clients with commercial manufacturing requirements.
